COMPANY |
Novavax, Inc |
COURT |
United States District Court for the District of Maryland |
CASE NUMBER |
21-cv-02910 |
JUDGE |
The Honorable Theodore D. Chuang |
CLASS PERIOD |
March 2, 2021 and October 19, 2021 |
SECURITY TYPE |
All Securities |
Case Background:
A class action lawsuit has been filed on behalf of those who purchased or acquired Novavax, Inc. (“Novavax”) (NASDAQ: NVAX) securities between March 2, 2021 and October 19, 2021, both dates inclusive (the “Class Period”).
The complaint alleges that throughout the Class Period, the Defendants made false and/or misleading statements and/or failed to disclose that: (1) Novavax overstated its manufacturing capabilities and downplayed manufacturing issues that would impact its approval timeline for NVX-CoV2373; (2) as a result, Novavax was unlikely to meet its anticipated EUA regulatory timelines for NVX-CoV2373; (3) accordingly, Novavax overstated the regulatory and commercial prospects for NVX-CoV2373; and (4) as a result, Novavax’s public statements were materially false and misleading at all relevant times.
Current Status of Case:
On December 1, 2023, the parties advised the Court that they had agreed to settle the action. On January 23, 2024, the Court issued an Order granting Lead Plaintiffs’ Motion for Preliminary Approval of Class Action Settlement and scheduled a Final Settlement Hearing on May 23, 2024. This action is ongoing.
The deadline to file a claim is May 18, 2024. If you have any questions or need further information about this settlement, you may go to the following website www.strategicclaims.net/novavax/, or you can contact the claims administrator, Strategic Claims Services at 1-866-274-4004.
If you wish to discuss this action or have any questions concerning this notice or your rights or interests with respect to these matters, please contact Kessler Topaz Meltzer & Check, LLP: Jon Naji, Esq. (484) 270-1453; or via e-mail at info@ktmc.com. If you would like additional information about the suit, please click on the link "Submit Your Information" above and fill out the form as promptly as possible.